Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics
Olivier Le Tilly(Université de Tours), David Ternant(Université de Tours), Gilles Paintaud(Université de Tours), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Christophe Passot(Université de Tours), Sophie Caillard(Hôpitaux Universitaires de Strasbourg), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Rébecca Sberro‐Soussan(Hôpital Necker-Enfants Malades), Céline Desvignes(Université de Tours), Saida Semlali(Centre Hospitalier Universitaire de Tours), Dominique Bertrand(Université de Rouen Normandie)
Cited by 4
Related Papers
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study
|Radiology|2020|472
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population
|Kidney International|2000|191
Acute Renal Infarction
|Clinical Journal of the American Society of Nephrology|2012|176